FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 356:305-307 January 18, 2007 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Mas, J.-L. PubMed Citation

To the Editor: Mas et al. (Oct. 19 issue)¹ report the results of the randomized Endarterectomy versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial, which suggest the superiority of carotid endarterectomy over carotid-artery stenting in patients with symptomatic stenosis of at least 60%. The results are similar to the recently reported findings in the Stent-Protected Angioplasty versus Carotid Endarterectomy in Symptomatic Patients (SPACE) study.² However, some points deserve comment. First, the most active center in the trial included few patients (approximately 10 per year). Second, in an important proportion of cases (5%), carotid-artery stenting failed and endarterctomy . . . [Full Text of this Article]

This article has been cited by other articles:

• Hobson, R. W. II (2007). Randomized Clinical Trials: Impact on Clinical Practice for Symptomatic and Asymptomatic Extracranial Carotid Occlusive Disease. PERSPECT VASC SURG ENDOVASC THER 19: 215-219 [Abstract]